Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-208411
Filing Date
2025-09-19
Accepted
2025-09-19 10:46:11
Documents
2
Period of Report
2025-09-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4567
2 EX-24 achv-ex24.htm EX-24 12471
  Complete submission text file 0001193125-25-208411.txt   18689
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 22722 29TH DR. SE SUITE 100 BOTHELL WA 98021
Business Address
Donnelly Craig (Reporting) CIK: 0002086790 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 251325399